Berkshire Capital Holdings’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1K Sell
10
-87,920
-100% -$12.5M ﹤0.01% 74
2025
Q4
$14.6M Buy
87,930
+87,920
+879,200% +$14.7M 4.85% 8
2025
Q3
$1.96K Hold
10
﹤0.01% 57
2025
Q2
$904 Hold
10
﹤0.01% 75
2025
Q1
$597 Sell
10
-121,340
-100% -$11.2M ﹤0.01% 76
2024
Q4
$16.1M Buy
+121,350
New +$11.4M 5.81% 6

Other funds holding ALAB

Berkshire Capital Holdings's ALAB Position: Q1 2026 in Review

Berkshire Capital Holdings reduced its Astera Labs (ALAB) stake by 100% in Q1 2026, selling an estimated $12.5M and leaving 10 shares worth $1.1K. The position accounts for ﹤0.01% of the portfolio, ranked #74.

Berkshire Capital Holdings first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $16.1M in Q4 2024. 707 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Berkshire Capital Holdings held 10 shares of Astera Labs worth $1.1K as of Q1 2026.
  • Berkshire Capital Holdings sold 87,920 Astera Labs shares in Q1 2026, an estimated $12.5M.
  • Astera Labs made up ﹤0.01% of Berkshire Capital Holdings's portfolio in Q1 2026, its #74 holding.
  • Berkshire Capital Holdings first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Berkshire Capital Holdings's Astera Labs position peaked at $16.1M in Q4 2024.
  • 707 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Berkshire Capital Holdings's 13F filing for Q1 2026, filed 12 May 2026.